Skip to main content

Advertisement

Table 5 Clinical outcomes. Mean (SD) unless otherwise stated

From: The effect of targeted treatment on people with patellofemoral pain: a pragmatic, randomised controlled feasibility study

Outcome Group Baseline (SD) Post treatment (SD) Mean difference (baseline –post) (SD) Confidence intervals (95%) Mean difference (MT-Control) (95% CI) ES (d) (MT- control)
AKPS MT 75.08 (10.09) 80.31 (8.66) −5.23 (10.17) −11.37, 0.91 −6.41 (−14.23, 1.41) 0.70
UC 73.64 (12.23) 72.45 (16.94) 1.18 (7.91) −4.13, 6.49
Worst NRS MT 4.85 (1.68) 4.62 (2.10) 0.23 (2.05) −1.01, 1.47 −0.41 (−1.93, 1.12) 0.23
UC 5.27 (2.33) 4.64 (2.16) 0.64 (1.43) −0.33, 1.59
Average NRS MT 3.08 (1.38) 2.46 (1.33) 0.62 (1.33) −0.19, 1.42 −0.02 (−1.01, 0.96) 0.02
UC 3.73 (2.19) 3.09 (1.87) 0.64 (0.92) 0.02, 2.28
GROC MT   61.5% (8/13)     
UC   9.1% (1/11)     
  1. AKP anterior knee pain scale, MT matched treatment, UC usual care group, NRS numerical rating scale, GROC global rating of change scale, ES effect size